# Alpha MSH in Ocular Disease

> **NCT03451578** · NA · COMPLETED · sponsor: **Duke University** · enrollment: 54 (actual)

## Conditions studied

- Advanced Dry Macular Degeneration

## Interventions

- **DEVICE:** Alpha MSH assay

## Key facts

- **NCT ID:** NCT03451578
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-06
- **Primary completion:** 2021-10-19
- **Final completion:** 2021-10-19
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2022-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03451578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03451578, "Alpha MSH in Ocular Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03451578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*